- Home
- RGF vs SHPH Comparison
RGF vs SHPH Comparison
Compare RGF & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGF
- SHPH
- Stock Information
- Founded
- RGF 2016
- SHPH 2012
- Country
- RGF United States
- SHPH United States
- Employees
- RGF N/A
- SHPH N/A
- Industry
- RGF Packaged Foods
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- RGF Consumer Staples
- SHPH Health Care
- Exchange
- RGF Nasdaq
- SHPH Nasdaq
- Market Cap
- RGF 8.3M
- SHPH 3.3M
- IPO Year
- RGF 2021
- SHPH 2022
- Fundamental
- Price
- RGF $0.36
- SHPH $1.41
- Analyst Decision
- RGF Hold
- SHPH
- Analyst Count
- RGF 1
- SHPH 0
- Target Price
- RGF $0.50
- SHPH N/A
- AVG Volume (30 Days)
- RGF 1.2M
- SHPH 43.1K
- Earning Date
- RGF 11-08-2024
- SHPH 11-12-2024
- Dividend Yield
- RGF N/A
- SHPH N/A
- EPS Growth
- RGF N/A
- SHPH N/A
- EPS
- RGF N/A
- SHPH N/A
- Revenue
- RGF $156,379,000.00
- SHPH N/A
- Revenue This Year
- RGF $23.67
- SHPH N/A
- Revenue Next Year
- RGF N/A
- SHPH N/A
- P/E Ratio
- RGF N/A
- SHPH N/A
- Revenue Growth
- RGF 18.88
- SHPH N/A
- 52 Week Low
- RGF $0.21
- SHPH $1.03
- 52 Week High
- RGF $2.75
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- RGF 45.74
- SHPH 49.84
- Support Level
- RGF $0.33
- SHPH $1.12
- Resistance Level
- RGF $0.40
- SHPH $1.26
- Average True Range (ATR)
- RGF 0.04
- SHPH 0.11
- MACD
- RGF 0.00
- SHPH 0.06
- Stochastic Oscillator
- RGF 56.82
- SHPH 68.09
About RGF The Real Good Food Company Inc.
The Real Good Food Company Inc is an high-growth, branded, health- and wellness-focused frozen food company. It develops, markets, and manufactures delicious and convenient comfort foods designed to be high in protein, low in sugar, and made from gluten- and grain-free ingredients that are intended to be sold in the health and wellness segment of the frozen food category. All of its revenue is derived from the United States.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.